Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-23-050223

Director sold 4,359 shares at $0.69 ($3,008)

From the SEC's structured data for this filing

Trades in this filing

Curet Myriam · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-18 Sale : show line 1 in the form −4,359 $0.69 $3,008 27,418 D
Open-market sales · 4,359 sh · avg $0.69 · $3,008

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-19 Grant or award : show line 2 in the form Stock Option +85,000 85,000 D
Loading xslF345X05/doc4.xml…